Lupin informs about press release

15 Feb 2024 Evaluate
Lupin has enclosed a Press Release regarrding, launch of Ganirelix Acetate Injection, 250 mcg/0.5 mL, Single-Dose Prefilled Syringe, after having received an approval from the US FDA. This is considered as a disclosure pursuant to Regulation 30 of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2160.00 12.45 (0.58%)
23-Dec-2024 13:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1815.75
Dr. Reddys Lab 1336.00
Cipla 1474.20
Lupin 2160.00
Zydus Lifesciences 974.45
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.